Sagetis Biotech
OverviewSuggest Edit
Sagetis Biotech is a company that develops a gene delivery technology. It provides a polymer-coated adenovirus for the treatment of pancreatic ductal adenocarcinoma.
| Type | Private | |
| Founded | 2010 | |
| Website | sagetis-biotech.com |
Latest Updates
| Employees (est.) (Jan 2021) | 1 | |
| Cybersecurity rating | B | More |
Sagetis Biotech Financials and Metrics
Summary Metrics
Founding Date | 2010 |
Sagetis Biotech total Funding | $2 m |
Sagetis Biotech latest funding size | $2 m |
Time since last funding | 10 years ago |
Sagetis Biotech investors | Caixa Capital Risc |
Sagetis Biotech's latest funding round in July 2011 was reported to be $2 m. In total, Sagetis Biotech has raised $2 m
Sagetis Biotech Cybersecurity Score
Sagetis Biotech Online and Social Media Presence
Sagetis Biotech's Trends
Sagetis Biotech Frequently Asked Questions
When was Sagetis Biotech founded?
Sagetis Biotech was founded in 2010.
How many employees does Sagetis Biotech have?
Sagetis Biotech has 1 employees.
Who are Sagetis Biotech competitors?
Competitors of Sagetis Biotech include Epify, Altheia Science and Rznomics.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies